FDA gives 1st emergency approval to antiviral pill to treat COVID-19 patients, from Pfizer

Further, the clinical studies observed mostly only mild side effects from the drug.

The FDA authorization makes the pill available to adults and children who have tested positive for COVID-19 and are considered likely to become severely ill. That includes older adults and those with heart disease and obesity.

Under the FDA authorization, children must weigh at least 88 pounds to qualify to take the medication.

“Today’s authorization of Paxlovid represents another tremendous example of how science will help us ultimately defeat this pandemic, which, even two years in, continues to disrupt and devastate lives across the world,” Pfizer CEO Albert Bourla said in a statement.

Read Full Story
UPI Rating

Share this:

Leave a Reply

%d bloggers like this: